SUMMARY Forty-three patients with glaucoma and 24 patients with ocular hypertension presenting with a retinal vein occlusion were medically assessed. The prevalence of systemic hypertension was 60.5% in those with glaucoma and 66-6% with ocular hypertension. The prevalence of hyperlipidaemia was 38-1% in those with glaucoma and 37-5% in those with ocular hypertension. These findings were compared with those from a carefully age-sex matched group of patients presenting with a retinal vein occlusion without evidence of glaucoma or ocular hypertension. There were no statistical differences between any of the groups (52.2% had systemic hypertension and 28.8% had hyperlipidaemia). There was also a strikingly high prevalence of systemic hypertension (89%) and hyperlipidaemia (55.5%) in nine of the patients who had evidence of a recurrent retinal vein occlusion associated with glaucoma, and these prevalence rates were strikingly similar to the rates in patients with recurrence but without glaucoma. The data suggest that glaucoma or ocular hypertension has a less prominent aetiological role in the development of a retinal vein occlusion than underlying medical causes and that full medical assessment is worthwhile.
sion. 7 The association between branch retinal vein occlusion and glaucoma is less clear.''6 However, hemisphere vein occlusion with the obstruction occurring at the edge of the optic cup is considered to be unquestionably related.8 From another point of view retinal vein occlusion has well established associated medical conditions, and a comparison between the prevalence in patients with retinal vein occlusion preceded by glaucoma or ocular hypertension, and patients with retinal vein occlusion without evidence of glaucoma or ocular hypertension, may give a hint to the importance of glaucoma or ocular hypertension in the aetiology of retinal vein occlusion.
We therefore performed a study to ascertain the prevalence of associated medical conditions in a group of patients with the combination of retinal vein occlusion and preceding glaucoma or ocular hyper- tension and compared them with a group of patients presenting with retinal vein occlusion without evidence of glaucoma or ocular hypertension who had been matched for age, sex, and vein occlusion type. The aetiological role of glaucoma or ocular hypertension in retinal vein occlusion and the value of medically investigating these patients is thus considered.
Patients and methods
Sixty-seven patients with retinal vein occlusion together with either glaucoma or ocular hypertension were assessed and divided into two groups. The first group included 43 patients with glaucoma who subsequently presented with a retinal vein occlusion. The second group included 24 patients with ocular hypertension who likewise presented with a retinal vein occlusion. The clinical details are presented in Table 1 . Patients were excluded if rubeosis was present at the time of the diagnosis of glaucoma or ocular hypertension.
We defined ocular hypertension as an intraocular pressure (LOP) of greater than 21 mm Hg9 in either 693 Results Tables 2 and 3 show the prevalence and mean values of associated medical diseases in the groups.
No statistical differences were observed in the prevalence of hypertension and hyperlipidaemia between the glaucoma or ocular hypertension groups and the matched groups, and the prevalence rates were also comparable in the glaucoma and the ocular hypertension groups. Diabetes mellitus was relatively uncommon in all three groups. Combining the glaucoma and ocular hypertension groups, we found a high prevalence of abnormally raised fibrinogen (mean 4.33 (SD 1-0) g/l, n=61; 37.7% >4.3 g/l), and immunoglobulin levels, especially IgA (mean 2-96 (SD 1.2) g/l, n=44; 25% >4-0 g/l). Only 24 patients had their plasma viscosity estimated, but 20 of these had levels of 1.8 cp or more. There were nine patients with raised haemoglobin levels (>16 g/dl), but none had a packed cell volume of greater than 50%. The mean erythrocyte sedimentation rates (ESR) were not significantly raised. Other important medical conditions were also identified in the two groups, and are presented in Table 4 .
Nine patients (13-4%) were recorded to be active smokers and 11 (16-4%) past smokers. Four had a moderate alcohol intake; one had a past history of high alcohol consumption.
Nine patients (13-4%) had evidence of a previous retinal vein occlusion in the other eye (that is, recurrent retinal vein occlusion). The prevalence of hypertension and hyperlipidaema in this group was strikingly high ( and ocular hypertension groups combined who had no associated medical conditions. Their mean IOP at the time of diagnosis was compared with that of the remaining patients, apart from those with neovascular glaucoma (Table 5 ). There was no statistical difference between the mean levels in the two groups. They were higher than 21 mm Hg in the affected eye in both groups (Table 6) . A similar result was also seen in the unaffected eye apart from eyes with rubeosis. The prevalence of associated medical conditions in patients with a central retinal vein occlusion were also analysed separately and compared with the prevalence rates in patients with the branch form. The results are presented in Table 7 , and shows a trend towards a slightly higher prevalence of both hypertension and hyperlipidaemia in patients with the branch form, especially hypertension in the ocular hypertensive group.
Shunt vessels on the optic disc may not be conclusive evidence of central retinal vein occlusion. However, removing from the analysis the six patients whose central retinal vein occlusion was diagnosed on the presence of collaterals on the optic disc makes no difference to the results.
Discussion
The relationship between glaucoma and central retinal vein occlusion was first recognised in 1913 by The explanation for the association between glaucoma and retinal vein occlusion has yet to be elucidated. Some authors have considered that these conditions are not related aetiologically but rather are both manifestations of some underlying vascular abnormality.4 15 Systemic hypertension is not related to chronic simple glaucoma; in fact the mean systolic blood pressure in patients with glaucoma has been shown to be low. 16 There are conflicting reports of the incidence of hyperlipidaemia in patients with glaucoma or ocular hypertension," 18 though risk factors in low tension glaucoma include hypertension, diabetes mellitus, hyperlipidaemia, and raised blood and plasma viscosities.'9 A similar IOP response to postural changes in eyes with chronic glaucoma and eyes following vein occlusion was suggested by Williams and Peart to be indicative of an underlying vascular abnormality." This may be particularly relevant in the case of retinal vein occlusion not related to raised TOP, as it is well documented that the primary event is endothelial cell proliferation in the vein wall associated either with degeneration of the endothelium and secondary thrombus formation or with severe phlebosclerosis.' The exact mechanism underlying the primary event is not clear, but clinical studies indicate that it is multifactorial, with cardiovascular risk factors such as hypertension and hyperlipidaemia prominent.' [22] [23] [24] Other abnormalities have been identified and include abnormal in-vivo platelet function,""26 hyperviscosity,27 and perhaps increased inflammatory activity. [27] [28] [29] The results in this study do, however, demonstrate that the prevalence of associated medical conditions in patients with retinal vein occlusion either with or without glaucoma or ocular hypertension are markedly similar. This observation holds for hypertension, hyperlipidaemia, diabetes mellitus, and smoking habits. The other abnormalities found with raised fibrinogen, IgA, and plasma viscosity levels are also consistent. The striking resemblance between those patients with recurrent retinal vein occlusion with preceding glaucoma or ocular hypertension and a previously reported group from the same hospital with recurrent retinal vein occlusion alone would also strongly support the similarity between the two groups.'2 These findings imply that glaucoma or ocular hypertension may not be the most important aetiological factor and that the associated medical conditions may be of greater significance.
The relationship between IOP, retinal blood flow, and systemic arterial pressure is complex. Under normal circumstances the ocular blood flow is chiefly determined by the level of the systemic arterial and intraocular pressures, the blood viscosity, and the state of the blood vessels supplying the eyes.' In response to raised IOP autoregulation occurs, with an increase of pressure in the arteries outside the eye and decreased vascular resistance in the retina to maintain normal blood flow.3'
It may be that for these patients with a compromised circulation, and possibly compromised autoregulatory mechanisms, a minor rise in IOP is high enough to reduce ocular blood flow sufficiently to propagate stagnant blood flow. This hypothesis is supported by the finding of a reduction in IOP thresholds, normally estimated to be [27] [28] [29] [30] Management of a patient with a retinal vein occlusion with or without glaucoma or ocular hypertension should include the identification and treatment of common conditions which appear to have an aetiological role in retinal vein occlusion. Other serious medical disorders, including carcinoma of breast, myeloma, and chronic lymphatic leukaemia, were identified in our group, and emphasise the importance of medical investigation.
Retinal vein occlusion appears to be linked with an increase in vascular causes of death (cardiac and cerebral),36 and there is evidence that treatment of hypertension and hyerlipidaemia can reduce the severity of some of its complications. Identification of these factors should therefore offer an opportunity for effective therapy."37 " Indeed the result in reducing the rate of devastating recurrence of retinal vein occlusion from 10-15%, as previously reported, to 1%, as suggested in a preliminary study after a fiveyears follow-up,22 is encouraging.
However tenuous the evidence may be, control of the 1OP on theoretical grounds should still be considered important. It may also be important to establish the effect of drugs on the capacity of the autoregulatory mechanisms in the retina. Grunwald found that timolol enhances autoregulation of retinal blood flow, and suggested that this may help perfusion following retinal vein occlusions.4" Other antiglaucoma drugs may affect this capacity. The treatment given for controlling systemic hypertension may also affect the control of the 1OP, and perhaps autoregulation. These factors need further investigation.
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